DE3863625D1 - Waessrige zubereitung des 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)-pyrimidin-4-one-kaliumsalzes. - Google Patents

Waessrige zubereitung des 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)-pyrimidin-4-one-kaliumsalzes.

Info

Publication number: DE3863625D1
Authority: DE; Germany
Prior art keywords: tetrazol; pyrido; pyrimidin; methyl; potassium salts
Prior art date: 1987-11-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE8888310599T

Other languages

English (en)

Inventor

Takashi Yazaki

Kazunori Takuma

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Mitsubishi Tokyo Pharmaceuticals Inc

Original Assignee

Tokyo Tanabe Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-11-10

Filing date

1988-11-10

Publication date

1991-08-14

1988-11-10 Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd

1991-08-14 Application granted granted Critical

1991-08-14 Publication of DE3863625D1 publication Critical patent/DE3863625D1/de

2008-11-11 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DE8888310599T 1987-11-10 1988-11-10 Waessrige zubereitung des 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)-pyrimidin-4-one-kaliumsalzes. Expired - Fee Related DE3863625D1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP62282064A JP2504788B2 (ja)	1987-11-10	1987-11-10	９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤

Publications (1)

Publication Number	Publication Date
DE3863625D1 true DE3863625D1 (de)	1991-08-14

Family

ID=17647679

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8888310599T Expired - Fee Related DE3863625D1 (de)	1987-11-10	1988-11-10	Waessrige zubereitung des 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)-pyrimidin-4-one-kaliumsalzes.

Country Status (7)

Country	Link
US (1)	US4977157A (de)
EP (1)	EP0316174B1 (de)
JP (1)	JP2504788B2 (de)
AU (1)	AU603712B2 (de)
CA (1)	CA1317230C (de)
DE (1)	DE3863625D1 (de)
ES (1)	ES2029030T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3882042T2 (de) *	1987-12-25	1993-09-30	Santen Pharma Co Ltd	Antiallergische augentropfen.
JP3310994B2 (ja) *	1991-07-03	2002-08-05	電気化学工業株式会社	アレルギー治療剤
US5527802A (en) *	1992-10-01	1996-06-18	Bristol-Myers Squibb Company	New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
WO2006099651A1 (de) *	2005-03-24	2006-09-28	Unipack Ges.M.B.H.	Flüssige, wässrige darreichungsform für sublinguale oder nasale anwendungen von aminorgruppen aufweisenden wirkstoffen
CN101610765A (zh) *	2006-12-18	2009-12-23	卡多兹公司	用于治疗炎症的新组合物
WO2008075028A1 (en) *	2006-12-20	2008-06-26	Cardoz Ab	New combination for use in the treatment of inflammatory disorders
AU2008273997A1 (en) *	2007-07-11	2009-01-15	Cardoz Ab	Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a PPAR gamma agonist
WO2009007679A2 (en) *	2007-07-11	2009-01-15	Cardoz Ab	Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
WO2009007675A2 (en) *	2007-07-11	2009-01-15	Cardoz Ab	Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
HUE032978T2 (hu)	2009-06-16	2017-11-28	Rspr Pharma Ab	Pemirolaszt kristályos formában
US20160243122A1 (en)	2014-10-23	2016-08-25	Rspr Pharma Ab	Use of pemirolast in the treatment of acute asthma
WO2016102941A1 (en)	2014-12-22	2016-06-30	Rspr Pharma Ab	New combination of pemirolast and montelukast
GB201518831D0 (en)	2015-10-23	2015-12-09	Rspr Pharma Ab	New use
CN116531383A (zh) *	2023-05-09	2023-08-04	安徽四环科宝制药有限公司	含吡嘧司特钾的药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4122274A (en) *	1977-05-25	1978-10-24	Bristol-Myers Company	3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
US4457932A (en) *	1983-07-22	1984-07-03	Bristol-Myers Company	Anti-ulcer agents
DE3882042T2 (de) *	1987-12-25	1993-09-30	Santen Pharma Co Ltd	Antiallergische augentropfen.

1987
- 1987-11-10 JP JP62282064A patent/JP2504788B2/ja not_active Expired - Fee Related
1988
- 1988-10-25 AU AU24334/88A patent/AU603712B2/en not_active Ceased
- 1988-10-27 US US07/264,439 patent/US4977157A/en not_active Expired - Fee Related
- 1988-11-02 CA CA000581966A patent/CA1317230C/en not_active Expired - Fee Related
- 1988-11-10 EP EP88310599A patent/EP0316174B1/de not_active Expired - Lifetime
- 1988-11-10 ES ES198888310599T patent/ES2029030T3/es not_active Expired - Lifetime
- 1988-11-10 DE DE8888310599T patent/DE3863625D1/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2029030T3 (es)	1992-07-16
EP0316174A1 (de)	1989-05-17
JP2504788B2 (ja)	1996-06-05
US4977157A (en)	1990-12-11
AU603712B2 (en)	1990-11-22
EP0316174B1 (de)	1991-07-10
AU2433488A (en)	1989-05-11
JPH01125321A (ja)	1989-05-17
CA1317230C (en)	1993-05-04

Similar Documents

Publication	Publication Date	Title
DE3168433D1 (de)	1985-03-07	3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidin-4-one derivatives
DE3863625D1 (de)	1991-08-14	Waessrige zubereitung des 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)-pyrimidin-4-one-kaliumsalzes.
FI883807A (fi)	1989-02-22	Menetelmä farmakologisesti aktiivisten 7-(3-substituoitu-1-pyrrolidinyyli)-1-syklopropyyli-1,4-dihydro-4-okso-1,8-naftyridiini-3-karboksyylihappojohdannaisten valmistamiseksi
DK495287D0 (da)	1987-09-21	2-eller 3-arylsubstituerede imidazo(1,2-a)pyridi ner
ATE83148T1 (de)	1992-12-15	Topische ofloxacin enthaltende zubereitung.
NO884329L (no)	1988-09-29	Fremgangsmaate for fremstilling av vannfritt, krystallinsknatriumsalt av 5-klor-3-(2-tenoyl)-2-oksindol-1-karboksamid.
DE3888897D1 (de)	1994-05-11	Imidazo[1,2-b]pyridazinderivate.
NO163856C (no)	1990-08-08	Fremgangsmaate til fremstilling av ikke-toksiske salter av6-metyl-3,4-dihydro-1,2,3-oksatiazin-4-on-2,2-dioksyd.
NO874302D0 (no)	1987-10-15	Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo (1,5-a)pyrimidiner.
NO893106L (no)	1990-02-05	Visse imidazo(4,5-b)pyridinderivater.
GR870783B (en)	1987-09-25	Diastereoisomeric tetrahydropyrido (2,3-d) pyrimidine derivatives
DK307387A (da)	1987-12-31	4(3h)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidinderivater
DE3682244D1 (de)	1991-12-05	Substituierte dihydroimidazo(1,2-a)chinoxalinderivate.
RU93004774A (ru)	1996-11-27	Производные амида 4-оксо-4h-пиридо(1,2-а)-пиримидин-3-карбоновой кислоты или их кислотно-аддитивные соли
NO903591D0 (no)	1990-08-15	Fremgangsmaate for fremstilling av pyrido(3,4-b)(1,4)benzoksazepiner samt anvendelse som medikamenter.
ES2023410B3 (es)	1992-01-16	Acidos 1,3,4,9-tetrahidropiran 3,4-b]indol -1 aceticos sustituidos.
DK33684D0 (da)	1984-01-25	Pyrazino (2',3'-3,4)pyrido(1,2-a)-indol-derivater
DK282988D0 (da)	1988-05-24	Imidazo(1,2-a)pyrimidiner og salte deraf, deres fremstilling og laegemidler med indhold deraf
DK456986A (da)	1987-03-26	9-(substitueret thio)-4h-pyrido(1,2-a)-pyrimidin-4-on-derivater
NO166128C (no)	1991-06-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(1,2-a)pyridinderivater.
NO903778L (no)	1991-03-01	Fremgangsmaate for fremstilling av terapeutisk aktive pyrido(2,3-b)-benzazepin- (og -tiazepin)-5(6h)-on-derivater.
NO880127D0 (no)	1988-01-13	Fremgangsmaate for fremstilling av (+-)-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1,7-dicarboxylater.
IT8622018A0 (it)	1986-10-15	Azinil)pirido(2,3-d)pirimidin-6-carprocedimento per la preparazione bossilico. dell'acido 5,8-diidro-8-etil-5-osso-2-(1-piper
FR2342970A1 (fr)	1977-09-30	Derives de pyrazolo(1,5-a)pyrazolo(4',3': 5,6)pyrido(3,4-e)pyrimidine
ATE63120T1 (de)	1991-05-15	4(3h)-oxo-5,6,7,8-tetrahydropyrido(2,3d>pyrimidinderivate.

Legal Events

Date	Code	Title	Description
1992-08-06	8364	No opposition during term of opposition
2000-08-31	8327	Change in the person/name/address of the patent owner	Owner name: MITSUBISHI-TOKYO PHARMACEUTICALS, INC., TOKIO, JP
2003-09-11	8339	Ceased/non-payment of the annual fee